netilmicin ( ntl ) , a new semisynthesized aminoglycoside , was evaluated in 11 episodes of infection in 10 patients , who had severe underlying diseases , such as acute myocardial infarction , cerebral infarction , malignancy and hepatic cirrhosis .
C0027780
netilmicin
C0002556
aminoglycoside